Eli Lilly confirmed that it will allow more patients to apply for early access to retatrutide, an unapproved obesity drug ...

It is no longer possible to ask the FDA to keep pace with software development by doing the same reviews faster,” writes Dana ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Medicare is removing flexibilities that have allowed "breakthrough" medical devices to leapfrog qualifications for extra ...

Two people have died in the cyclospora outbreak in Michigan in the first confirmed deaths in the U.S. related to the ...

The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a "duty" to ...

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. In the last three decades, as ...

Six weeks after STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of ​the ...

Medicaid work requirements in effect in Nebraska, AI scribes in med school, and more health news from Morning Rounds ...